NICB selects Ocimum's Biotracker

17 July 2005

Hyderabad, India-headquartered Ocimum Biosolutions, a provider of laboratory information management system and bioinformatics solutions, says that the National Institute for Cellular Biotechnology, at Ireland's Dublin City University, has acquired its Biotracker LIMS solution to provide centralized, secure, privilege-driven access to researchers working in its gene expression and proteomics groups.

This database can assist researchers to track samples, growth conditions, clinical history, extraction information and isolated RNA and/or cell fraction details. Biotracker can also provide connectivity to existing databases at DCU, in a secure archival format with scope for future data-mining, says Ocimum.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight